Table 3

Clinical outcomes in vitamin D treated and placebo patients

Vitamin D groupPlacebo group
Baseline12 monthsBaseline12 monthsp Value
EDSS (mean (SE))2.0 (0.2)1.8 (0.2)1.5 (1.2)1.6 (1.3)0.071
Change−0.20 (0.1)−0.02 (0.1)
ARR (mean (SE))0.49 (0.5)0.26 (0.5)0.51 (0.5)0.28 (0.6)NS
95% CI0.31 to 0.660.08 to 0.440.33 to 0.700.07 to 0.49
TTW10 (mean (SE))11.7 (1.1)9.7 (0.7)9.6 (1.0)11.2 (1.9)0.076
Change−2.44 (0.8)0.95 (1.1)
T25FW (mean (SE))6.0 (0.9)5.3 (0.2)4.7 (1.4)5.1 (1.3)0.932
Change−0.62 (1.0)0.30 (0.9)
  • ARR, annual relapse rate; Change, from baseline to 12 months; EDSS, Expanded Disability Status Scale; T25FW, timed 25 foot walk; TTW10, timed 10 foot tandem walk.